Request Trial
21 May 2024NewsCareersMuireann Bolger

Polsinelli hires ‘valuable asset’ for Denver office

Experienced patent attorney represents clients in a wide range of industries, including renewable energy, semiconductors and artificial intelligence.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Week Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Atif Choudhury at achoudhury@lifesciencesipreview.com 


More on this story

Careers
Latham lands pharma and tech expert in London
29 October 2026   The US firm has added a top litigator with experience in pharmaceutical disputes, AI and technology, and complex cross-border litigation, who also made history as the youngest person appointed deputy master of the High Court’s Business and Property Division.
Careers
Womble Bond Dickinson loses trio of partners to US rival
27 October 2026   The departing partners bring expertise across molecular biology, biochemistry, small molecule and peptide drugs, including blockbuster therapies, as well as chemical and mechanical technologies.
Careers
Fish & Richardson hires duo with ‘sophisticated’ tech patent expertise
21 October 2026   With specialisms covering AI, electrical, manufacturing and engineering, the pair move from Brownstein, following a former colleague who joined the firm earlier this year.


Editor's picks

WATCH: Medmix global IP head on building business-focused IP teams
In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026

Editor's picks

In-house counsel
WATCH: Medmix global IP head on building business-focused IP teams
21 October 2026
MedTech
Boston Scientific expands dispute with J&J unit over cardiac-access technology
12 October 2026
Pharma
Dr Reddy’s v Boehringer: Data gaps take centre stage in courtroom
6 October 2026
In-house counsel
WATCH: Genevant IP director on tackling UPC-EPO opposition divide
1 October 2026
Pharma
Lilly loses Fed Circ rehearing bid, sparking enablement questions
1 October 2026
Pharma
Takeda sees off UK challenge to Elvanse SPC
28 September 2026

More features

Oura targets Ultrahuman’s redesigned smart ring following import ban
Weil collapse leaves IP talent facing uncertain future after major expansion
Meril turns the tables on Edwards with European patent revocation
Latham lands pharma and tech expert in London
Regeneron and Amgen call a truce on two Eylea biosimilar patents
HeartFlow targets AI cardiac imaging rival over patents and trade secrets
Womble Bond Dickinson loses trio of partners to US rival
‘Companies that don’t leverage AI will struggle to keep up’: Umicore IP chief